<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03030742</url>
  </required_header>
  <id_info>
    <org_study_id>NortherwesternU</org_study_id>
    <nct_id>NCT03030742</nct_id>
  </id_info>
  <brief_title>Postpartum Opioid Prescribing Patterns and Patient Utilization</brief_title>
  <official_title>Postpartum Opioid Prescribing Patterns and Patient Utilization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Society for Maternal-Fetal Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to investigate the prescribing patterns and patient utilization of opioid
      pain medication in the postpartum setting. Postpartum women will be surveyed prior to
      hospital discharge and again at 2-4 weeks postpartum in order to assess the number of opioid
      tablets they used (in relation to the number prescribed), pain satisfaction, and
      storage/disposal of any remaining opioid tablets.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Opiate abuse is a national epidemic and has paralleled the increase in opioid prescriptions,
      with diversion of surplus medication playing a key contributing role. As the majority of
      reproductive age women in the U.S. will experience childbirth, understanding opioid
      prescription patterns and patient opioid utilization in the postpartum period is critical.

      Postpartum women will be recruited during a 9-month period to take part in pre-hospital
      discharge and 2-4 week postpartum surveys to prospectively assess opioid medication use with
      regard to quantity of opioid tablets prescribed and quantity used, storage and disposal of
      unused opioids and satisfaction with pain control.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postpartum outpatient opioid use</measure>
    <time_frame>8 weeks</time_frame>
    <description>Self reported number of opioid tablets used at time of postpartum survey administered 2-4 weeks postpartum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with outpatient pain control</measure>
    <time_frame>8 weeks from time of hospital discharge</time_frame>
    <description>Satisfaction with pain control at the time of postpartum survey administered 2-4 weeks postpartum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proper disposal/storage of remaining opioid tablets</measure>
    <time_frame>8 weeks from time of discharge</time_frame>
    <description>Proportion of patients who report proper disposal/storage of remaining opioid tablets at the time of postpartum survey administered 2-4 weeks postpartum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High opioid use</measure>
    <time_frame>8 weeks from time of hospital discharge</time_frame>
    <description>Comparison of characteristics of women with &gt;50% remaining versus &lt;50% remaining of prescribed opioid tablets</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Postpartum</condition>
  <condition>Opioid Use</condition>
  <condition>Post-operative</condition>
  <condition>Cesarean Delivery</condition>
  <arm_group>
    <arm_group_label>Post-cesarean delivery</arm_group_label>
    <description>Women who have undergone cesarean delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-vaginal delivery</arm_group_label>
    <description>Women who have undergone vaginal delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey</intervention_name>
    <description>A survey will be administered at two time points (time of hospital discharge and 2-4 weeks postpartum) to determine:
Satisfaction with pain control 2-4 weeks postpartum
Patient-reported use of opioid medication postpartum (receipt of prescription, filling of prescription, if refill was obtained, and number of opioid pills remaining at the time of follow-up)
Patient characteristics associated with high opioid use
Methods of storage and disposal of unused opioids</description>
    <arm_group_label>Post-cesarean delivery</arm_group_label>
    <arm_group_label>Post-vaginal delivery</arm_group_label>
    <other_name>Survey/Questionnaire</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women who are postpartum
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women who deliver during the recruitment period

          -  English-speaking

          -  Opiate-na√Øve (as determined by admission medication reconciliation)

          -  Receive oral opioid medications during inpatient postpartum admission

          -  18 years or older

        Exclusion Criteria:

          -  Contraindication to NSAID use

          -  Required use of general anesthesia without concurrent neuraxial analgesia

          -  Undergo hysterectomy, or unanticipated surgical procedures during the postpartum
             period

          -  Are admitted to the intensive care unit during their admission.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Nevert Badreldin, MD</last_name>
    <phone>312.472.4648</phone>
    <email>nevert.badreldin@northwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lynn Yee, MD</last_name>
    <phone>312.472.0119</phone>
    <email>lynn.yee@northwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nevert Badreldin, MD</last_name>
      <phone>312-472-4648</phone>
      <email>nevert.badreldin@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Nevert Badreldin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lynn Yee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013 Jul 5;62(26):537-42.</citation>
    <PMID>23820967</PMID>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. MMWR Morb Mortal Wkly Rep. 2011 Nov 4;60(43):1487-92.</citation>
    <PMID>22048730</PMID>
  </reference>
  <reference>
    <citation>Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS, Boswell MV. Opioid epidemic in the United States. Pain Physician. 2012 Jul;15(3 Suppl):ES9-38. Review.</citation>
    <PMID>22786464</PMID>
  </reference>
  <reference>
    <citation>Pfuntner A, Wier LM, Stocks C. Most Frequent Procedures Performed in U.S. Hospitals, 2010: Statistical Brief #149. 2013 Feb. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-. Available from http://www.ncbi.nlm.nih.gov/books/NBK132428/</citation>
    <PMID>23596641</PMID>
  </reference>
  <reference>
    <citation>Peirce GL, Smith MJ, Abate MA, Halverson J. Doctor and pharmacy shopping for controlled substances. Med Care. 2012 Jun;50(6):494-500. doi: 10.1097/MLR.0b013e31824ebd81.</citation>
    <PMID>22410408</PMID>
  </reference>
  <reference>
    <citation>Bates C, Laciak R, Southwick A, Bishoff J. Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice. J Urol. 2011 Feb;185(2):551-5. doi: 10.1016/j.juro.2010.09.088. Epub 2010 Dec 18.</citation>
    <PMID>21168869</PMID>
  </reference>
  <reference>
    <citation>Hill MV, McMahon ML, Stucke RS, Barth RJ Jr. Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures. Ann Surg. 2017 Apr;265(4):709-714. doi: 10.1097/SLA.0000000000001993.</citation>
    <PMID>27631771</PMID>
  </reference>
  <reference>
    <citation>Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378-82. doi: 10.15585/mmwr.mm6450a3.</citation>
    <PMID>26720857</PMID>
  </reference>
  <reference>
    <citation>Paulozzi LJ, Mack KA, Hockenberry JM; Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012. MMWR Morb Mortal Wkly Rep. 2014 Jul 4;63(26):563-8.</citation>
    <PMID>24990489</PMID>
  </reference>
  <reference>
    <citation>Mkontwana N, Novikova N. Oral analgesia for relieving post-caesarean pain. Cochrane Database Syst Rev. 2015 Mar 29;(3):CD010450. doi: 10.1002/14651858.CD010450.pub2. Review.</citation>
    <PMID>25821010</PMID>
  </reference>
  <reference>
    <citation>Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008. Erratum in: J Pain. 2016 Apr;17(4):508-10. Dosage error in article text.</citation>
    <PMID>26827847</PMID>
  </reference>
  <reference>
    <citation>Bateman BT, Franklin JM, Bykov K, Avorn J, Shrank WH, Brennan TA, Landon JE, Rathmell JP, Huybrechts KF, Fischer MA, Choudhry NK. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-na√Øve women. Am J Obstet Gynecol. 2016 Sep;215(3):353.e1-353.e18. doi: 10.1016/j.ajog.2016.03.016. Epub 2016 Mar 17.</citation>
    <PMID>26996986</PMID>
  </reference>
  <reference>
    <citation>Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period. JAMA Intern Med. 2016 Sep 1;176(9):1286-93. doi: 10.1001/jamainternmed.2016.3298.</citation>
    <PMID>27400458</PMID>
  </reference>
  <reference>
    <citation>Bartels K, Mayes LM, Dingmann C, Bullard KJ, Hopfer CJ, Binswanger IA. Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery. PLoS One. 2016 Jan 29;11(1):e0147972. doi: 10.1371/journal.pone.0147972. eCollection 2016.</citation>
    <PMID>26824844</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2017</study_first_submitted>
  <study_first_submitted_qc>January 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2017</study_first_posted>
  <last_update_submitted>July 14, 2017</last_update_submitted>
  <last_update_submitted_qc>July 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Lynn M Yee</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

